Logo image of EUDA

EUDA HEALTH HOLDINGS LTD (EUDA) Stock Fundamental Analysis

USA - NASDAQ:EUDA - VGG3142E1051 - Common Stock

2.1 USD
+0.05 (+2.44%)
Last: 10/31/2025, 8:00:02 PM
2.11 USD
+0.01 (+0.48%)
After Hours: 10/31/2025, 8:00:02 PM
Fundamental Rating

1

Taking everything into account, EUDA scores 1 out of 10 in our fundamental rating. EUDA was compared to 100 industry peers in the Health Care Providers & Services industry. EUDA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EUDA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EUDA had negative earnings in the past year.
In the past year EUDA has reported a negative cash flow from operations.
EUDA had negative earnings in 4 of the past 5 years.
EUDA had a negative operating cash flow in each of the past 5 years.
EUDA Yearly Net Income VS EBIT VS OCF VS FCFEUDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -904.54%, EUDA is not doing good in the industry: 98.02% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -904.54%
ROE N/A
ROIC N/A
ROA(3y)-557.55%
ROA(5y)-334.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EUDA Yearly ROA, ROE, ROICEUDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

With a Gross Margin value of 19.00%, EUDA is not doing good in the industry: 60.40% of the companies in the same industry are doing better.
EUDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EUDA Yearly Profit, Operating, Gross MarginsEUDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

EUDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EUDA has more shares outstanding
EUDA has a better debt/assets ratio than last year.
EUDA Yearly Shares OutstandingEUDA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
EUDA Yearly Total Debt VS Total AssetsEUDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -35.14, we must say that EUDA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -35.14, EUDA is doing worse than 92.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -35.14
ROIC/WACCN/A
WACC9.13%
EUDA Yearly LT Debt VS Equity VS FCFEUDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.18 indicates that EUDA may have some problems paying its short term obligations.
EUDA's Current ratio of 0.18 is on the low side compared to the rest of the industry. EUDA is outperformed by 93.07% of its industry peers.
A Quick Ratio of 0.15 indicates that EUDA may have some problems paying its short term obligations.
EUDA has a Quick ratio of 0.15. This is amonst the worse of the industry: EUDA underperforms 92.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.15
EUDA Yearly Current Assets VS Current LiabilitesEUDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

EUDA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.30%.
EUDA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.22%.
EPS 1Y (TTM)-9.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.3%
Revenue 1Y (TTM)8.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.22%

3.2 Future

Based on estimates for the next years, EUDA will show a very strong growth in Earnings Per Share. The EPS will grow by 58.59% on average per year.
Based on estimates for the next years, EUDA will show a very strong growth in Revenue. The Revenue will grow by 166.64% on average per year.
EPS Next Y106.06%
EPS Next 2Y58.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.08%
Revenue Next 2Y166.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

EUDA Yearly Revenue VS EstimatesEUDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 2024 2025 2026 10M 20M 30M 40M
EUDA Yearly EPS VS EstimatesEUDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 0.1 -0.1 -0.2 -0.3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EUDA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 102.94, EUDA can be considered very expensive at the moment.
EUDA's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.55, EUDA is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 102.94
EUDA Price Earnings VS Forward Price EarningsEUDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EUDA Per share dataEUDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

EUDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EUDA's earnings are expected to grow with 58.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.59%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EUDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EUDA HEALTH HOLDINGS LTD

NASDAQ:EUDA (10/31/2025, 8:00:02 PM)

After market: 2.11 +0.01 (+0.48%)

2.1

+0.05 (+2.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-14 2024-06-14
Earnings (Next)N/A N/A
Inst Owners2.27%
Inst Owner Change0%
Ins Owners18.48%
Ins Owner Change0%
Market Cap79.40M
Revenue(TTM)4.01M
Net Income(TTM)-15357200
Analysts82.86
Price Target6.12 (191.43%)
Short Float %0.53%
Short Ratio0.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)118.18%
EPS NY rev (3m)118.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 102.94
P/S 19.8
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)0.02
Fwd EY0.97%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.11
BVpS-0.07
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -904.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19%
FCFM N/A
ROA(3y)-557.55%
ROA(5y)-334.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.97%
Cap/Sales 2.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.15
Altman-Z -35.14
F-Score3
WACC9.13%
ROIC/WACCN/A
Cap/Depr(3y)24.68%
Cap/Depr(5y)21.79%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.3%
EPS Next Y106.06%
EPS Next 2Y58.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.22%
Revenue Next Year54.08%
Revenue Next 2Y166.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.27%
OCF growth 3YN/A
OCF growth 5YN/A

EUDA HEALTH HOLDINGS LTD / EUDA FAQ

What is the fundamental rating for EUDA stock?

ChartMill assigns a fundamental rating of 1 / 10 to EUDA.


What is the valuation status for EUDA stock?

ChartMill assigns a valuation rating of 2 / 10 to EUDA HEALTH HOLDINGS LTD (EUDA). This can be considered as Overvalued.


Can you provide the profitability details for EUDA HEALTH HOLDINGS LTD?

EUDA HEALTH HOLDINGS LTD (EUDA) has a profitability rating of 0 / 10.


Can you provide the financial health for EUDA stock?

The financial health rating of EUDA HEALTH HOLDINGS LTD (EUDA) is 0 / 10.